| Document |
Document Title |
|
WO/2021/066585A1 |
The present specification provides a Staphylococcus epidermidis strain deposited under accession no. KCTC13941BP and having immunity-enhancing activity.
|
|
WO/2021/062887A1 |
Provided is a straw biodegradable composite bacterial agent, said compound bacterial agent being a composition of Bacillus subtilis, Bacillus amyloliquefaciens, Bacillus cereus, Phanerochaete chrysosporium, and Trametes versicolor. Biode...
|
|
WO/2021/066549A1 |
The present invention relates to Lactobacillus acidophilus KBL409 strain and use thereof. The Lactobacillus acidophilus KBL409 strain (accession number KCTC 13518BP) according to the present invention reduces kidney inflammation and the ...
|
|
WO/2021/063355A1 |
Provided is a method for constructing food-grade ethanol-degrading Bacillus subtilis recombinant bacteria. The method integrates expression cassettes of two enzyme genes into the genome of Bacillus subtilis by means of double-crossover h...
|
|
WO/2021/062489A1 |
The present invention generally relates to a system and process for producing a biosurfactant, and more particularly to a system and process for producing a biosurfactant from at least one strain of Bacillus subtilis, and formulations wh...
|
|
WO/2021/057446A1 |
Mixed bacteria promoting black locust nodulation and nitrogen fixation, and an application thereof, in the technical field of microbiology. The mixed bacteria consist of Kocuria sp. X-22, Microbacterium sp. X-26 and Bacillus sp. X-28, ea...
|
|
WO/2021/057308A1 |
A use of Serratia marcescens in preparing a termite antifeedant. Serratia marcescens is used to prepare the termite antifeedant in the form of a Serratia marcescens bacterial culture solution. Serratia marcescens features simple culturin...
|
|
WO/2021/060945A1 |
The present invention pertains to a novel Akkermansia sp. strain and a use thereof. A novel Akkermansia sp. HB03 strain provided in the present invention lacks toxic genes and thus does not cause side effects in vivo, and also exhibits e...
|
|
WO/2021/057709A1 |
A method for producing astaxanthin, comprising: (a) acquiring vegetative cells of astaxanthin-producing Haematococcus pluvialis; (b) heterotrophically culturing the vegetative cells of astaxanthin-producing Haematococcus pluvialis in a n...
|
|
WO/2021/060657A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture thereof, an extract from the culture, and a use thereof for improving a skin condition.
|
|
WO/2021/060654A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture solution, an extract of a culture solution, and a use thereof for improving the condition of the skin.
|
|
WO/2021/060648A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture solution thereof, an extract of the culture solution, and uses of same for improving skin condition.
|
|
WO/2021/060650A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture medium, an extract of the culture medium, and uses thereof for improving skin condition.
|
|
WO/2021/057381A1 |
The present application provides a runway algae culturing system. The runway algae culturing system comprises a runway pond, a propelling component, first turbulence components, and second turbulence components; the runway pond comprises...
|
|
WO/2021/060656A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture medium, an extract of the culture medium, and uses thereof for improving skin condition.
|
|
WO/2021/058688A1 |
Lactobacillus reuteri strain having NCIMB accession number 42835 is from a novel phylogenetic clade and has unique immune-stimulatory properties and enhanced ecological performance in the human gut. A substrate for the strain, such as ra...
|
|
WO/2021/060658A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture medium, a culture medium extract, and use thereof for skin condition improvement.
|
|
WO/2021/060655A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture thereof, an extract from the culture, and a use thereof for improving a skin condition.
|
|
WO/2021/060651A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture medium, an extract of the culture medium, and uses thereof for improving skin condition.
|
|
WO/2021/060659A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture medium, an extract of the culture medium, and uses thereof for improving skin condition.
|
|
WO/2021/060653A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture medium, an extract of the culture medium, and uses thereof for improving skin condition.
|
|
WO/2021/060652A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture solution, an extract of a culture solution, and a use thereof for improving the condition of the skin.
|
|
WO/2021/060649A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture broth thereof, or an extract of the culture broth thereof, and use thereof for improving a skin condition.
|
|
WO/2021/056936A1 |
The present invention relates to the technical field of microbial pesticides, in particular to a polyketone compound having a trans-decalin ring and obtained from a solid fermentation product of the bacterial strain Penicillium sp. TR85 ...
|
|
WO/2021/057711A1 |
Provided is a method for producing astaxanthin, comprising: (a) performing heterotrophic cultivation of astaxanthin-producing Haematococcus pluvialis; (b) performing heterotrophic cultivation of the Haematococcus pluvialis obtained in st...
|
|
WO/2021/060647A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture thereof, an extract from the culture, and a use thereof for improving a skin condition.
|
|
WO/2021/053639A1 |
The present invention relates to novel bacterial strains, such as: B. breve BblBSCM (DSM 33231), B. breve BblBS02 (DSM 33232), B. animalis subsp. lactis BIIBS01 (DSM 33233) and L plantarum LpIBSOI (DSM 33234). Furthermore, the present in...
|
|
WO/2021/055661A1 |
A genetically modified bacterium for excreting fixed nitrogen (in the form of ammonia) is disclosed. The bacterium can be made by deleting at least a portion of the nifL gene of a diazotrophic γ-proteobacterium, and inserting a promoter...
|
|
WO/2021/047032A1 |
Primers for molecularly labeling a new strain of Flammulina fennae and a molecular labeling method. The primers for molecularly labeling Flammulina fennae HMGIM-A151357 comprise FAA-F-3 and FAA-R-4, or FAA-F-5 and FAA-R-7; FAA-F-3: GCATT...
|
|
WO/2021/047431A1 |
Provided are a fermentation culture medium and a fermentation method capable of increasing a yield of A40926 B0. The fermentation culture medium comprises an organic carbon source, an organic nitrogen source, and inorganic salt; the quan...
|
|
WO/2021/048362A1 |
Fermented milk products can provide multiple benefits. However, it was commonly believed that fermented milk products are not suitable for the administration to canids as e.g. dogs can be intolerant to lactose. The present invention prov...
|
|
WO/2021/047031A1 |
Provided are a novel strain as well as a molecular marker primer and a molecular marking method thereof, particularly, to a novel flammulina fennae strain as well as a molecular marker primer and a molecular marking method thereof. The n...
|
|
WO/2021/048350A1 |
Process for producing an ambient storage food product comprising providing a food product with a pH of between 3.4 and 4.4, subjecting the food product to a heat treatment to obtain a heat treated food product, adding aseptically to the ...
|
|
WO/2021/048645A1 |
The present invention relates to a process of naturally producing 2-PE by using Acinetobacter soli bacterium. For this purpose, A. soli strains selected from environmental isolates were cultured in a bioreactor under average fermentation...
|
|
WO/2021/046853A1 |
An aerobic treatment method for kitchen waste comprises the following steps: performing impurity removal processing on kitchen waste generated on the same day, so as to obtain a purified material; filtering out excess waste water, then p...
|
|
WO/2021/046858A1 |
Provided is a mixed bacteria used for aerobic treatment of kitchen waste, and a preparation method and application thereof. The mixed bacteria comprises Brevibacterium aureum, Pediococcus acidilactici, Bacillus licheniformis, Bacillus su...
|
|
WO/2021/044429A1 |
The present invention is directed to a an isolated bacterial strain belonging to the genus of Pseudomonas having a nematode chemotaxis-inducing activity, a composition comprising same, and methods of using same, such as for attracting a ...
|
|
WO/2021/042634A1 |
Disclosed is a fermentation optimization process for producing hyaluronidase by Lactobacillus plantarum, the process comprising the following steps: preparing a seed culture medium; inoculating Lactobacillus plantarum into the seed cultu...
|
|
WO/2021/044415A1 |
The present invention is directed to a method for determining predisposition to developing a metabolic syndrome or a condition associated therewith in a subject including determining the bacterial diversity in a facial skin of the subjec...
|
|
WO/2021/042321A1 |
Provided is a method for genetically modified MSCs for treatment of type 2 diabetes, and recombinant stem cells thereof; the recombinant stem cells can overexpress Exendin-4 protein. The recombinant stem cells can be used for preparing a...
|
|
WO/2021/040186A1 |
Disclosed are a novel Akkermansia muciniphila EB-AMDK27 strain having the effect of preventing or treating inflammatory disease or metabolic disease, and a pharmaceutical composition effective for preventing or treating inflammatory dise...
|
|
WO/2021/037166A1 |
Provided are an Escherichia coli strain K12-based recombinant strain or a derivative strain thereof after site-directed mutagenesis, a construction method therefor and use thereof. Said recombinant strain is subjected to site-directed mu...
|
|
WO/2021/040187A1 |
Disclosed are a novel Akkermansia muciniphila strain having the effect of preventing or treating inflammatory disease or metabolic disease, and a pharmaceutical composition effective for preventing or treating inflammatory disease or met...
|
|
WO/2021/040335A1 |
A novel strain of the present invention has resistance under anaerobic conditions and culture conditions containing an excessive amount of hydrogen peroxide, and therefore has resistance under reactive oxygen conditions, that is, a defen...
|
|
WO/2021/037465A1 |
The invention relates to an improved bacterial oil treatment composition or pool for handling a decommissioned oil cable, which may be laid in particular as part of a power grid in the ground. The present invention further relates to a b...
|
|
WO/2021/037165A1 |
Provided is a nucleotide sequence. The sequence is a sequence formed by mutation of a base at the 1049th site of a wild-type deoB gene coding sequence shown in SEQ ID NO: 1 or a promoter nucleotide sequence by mutation of a base at the -...
|
|
WO/2021/035421A1 |
Provided is a folate producing strain and the preparation and application thereof, in particular, the expression level of the endogenous folCgene in the engineered strain of the present invention is decreased, and the exogenous folC gene...
|
|
WO/2021/036788A1 |
Provided is a construction method for a 2-keto-L-gulonic acid production strain, comprising one or more of the following steps in any order: 1) interrupting a membrane-bound glucose dehydrogenase encoding gene in the chromosome of Tatume...
|
|
WO/2021/036348A1 |
Provided is a folate producing strain and the preparation and application thereof, in particular, the expression level of the endogenous folC gene in the engineered strain of the present invention is decreased, and the exogenous folC gen...
|
|
WO/2021/040472A1 |
The present invention relates to a novel Spirulina strain having a linear-type morphology. Cells of Spirulina strain can be harvested at high yield using the Spirulina strain of the present invention.
|
